Human epidermal growth factor receptor-3, human epidermal growth factor-receptor-4, and heregulin-α are some of the biomarkers related to gastric cancer currently being used for early detection, personalized treatment, and evaluation of the efficiency of the treatment. This evidence concerns the gene ERBB3 and gastric cancer.